Aracelis Z. Torres - Concepedia

Author

Aracelis Z. Torres

Flatiron Health (United States)ORCID

Also Known As

A. Torres, A.Z. Torres, Aracelis Torres, Aracelis Z Torres, Aracelis Z. Torres, Torres, Aracelis

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Flatiron Health (United States)United States Food and Drug Administration National Cancer Institute Foundation Medicine (United States)New York University

About

Aracelis Z. Torres is an author at Flatiron Health (United States) specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	127
2	Epidemiology	2	2	42
3	Health Sciences	1	1	16
4	Public Health	1	1	26
5	Biostatistics	1	1	26

Aracelis Z. Torres

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database Gaurav Singal, Peter G. Miller, Vineeta Agarwala, JAMA	2019	541
Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint Melissa D. Curtis, Sandra D. Griffith, Melisa Tucker, Health Services Research	2018	208
Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer Sean Khozin, Rebecca A. Miksad, Johan Adami, Cancer	2019	135
An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer Mark Stewart, Andrew D. Norden, Nancy A Dreyer, JCO Clinical Cancer Informatics	2019	129
Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval Sean Khozin, Amy P. Abernethy, Nathan C. Nussbaum, The Oncologist	2018	96
Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval Sean Khozin, Kenneth R. Carson, Jizu Zhi, The Oncologist	2018	75
An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database Gillis Carrigan, Samuel Whipple, Michael D. Taylor, Pharmacoepidemiology and Drug Safety	2019	57
Real-World Dosing Patterns and Outcomes of Patients With Metastatic Pancreatic Cancer Treated With a Liposomal Irinotecan Regimen in the United States Afsaneh Barzi, Rebecca A. Miksad, Andy Surinach, Pancreas	2020	39
Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer Alberto Morán, Pilar Iniesta, Cristina García-Aranda, Oncology Reports	2005	34
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers Anish Thomas, Idrees Mian, Camille Tlemsani, CHEST Journal Tobacco ControlOncologyMedicineSmoking Related Lung DiseasePathology	2020	33

Page 1